{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:17:13Z","timestamp":1793308633327,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite the abnormal expression of 18S rRNA m6A methyltransferase METTL5 being reported in some types of human malignancies, but its effect on hepatocellular carcinoma (HCC) remains to be unclear. This study aims to elucidate the influences of METTL5 on the carcinogenesis and progression of HCC. Expressions of METTL5 gene, transcript, protein, and promoter methylation in HCC were examined through multiple databases, c-BioPortal was used to confirm the genomic alterations of METTL5, the biological functions, target networks of kinases and microRNAs of METTL5, and its interactive differential genes were investigated through LinkedOmics. The possible correlation of METTL5 with the tumor-related infiltration of immune cells for HCC were explored comprehensively by using the online tools of TIMER and TISIDB. Expressions of METTL5 gene, mRNA, and protein were considerably overexpressed in HCC samples in comparison with healthy samples. The high methylation of the METTL5 promoter was observed in HCC tissues. Elevated METTL5 expression exhibited unfavorable survival outcomes in HCC patients. METTL5 expression were enriched in the signaling pathways of ribosome and oxidative phosphorylation, mismatch repair, and spliceosome through the involvement of several cancer-related kinases and miRNAs. The METTL5 expression has a positive correlation with the infiltration degree of B cells, CD8+\u2009T cells, CD4+\u2009T cells, macrophages, neutrophils, and dendritic cells in HCC. Marker genes of tumor immune-infiltrated cells have strong connection with METTL5. Furthermore, the upregulation of METTL5 was strongly correlated with the immune regulation of immunomodulators, chemokines, and chemokine receptors in the immune microenvironment. The oncogenesis and development of HCC are closely related to METTL5 expression, and the overexpression of METTL5 resulted in the poor survival outcome of HCC patients by regulating tumor immune microenvironment.<\/jats:p>","DOI":"10.1038\/s41598-023-37807-5","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T18:03:19Z","timestamp":1688407399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment"],"prefix":"10.1038","volume":"13","author":[{"given":"Lei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-lin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"37807_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva, A. Hepatocellular carcinoma. N. Engl. J. Med. 380, 1450\u20131462 (2019).","journal-title":"N. Engl. J. Med."},{"key":"37807_CR2","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359-386 (2015).","journal-title":"Int. J. Cancer"},{"key":"37807_CR3","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1245\/s10434-009-0383-y","volume":"16","author":"L Aldrighetti","year":"2009","unstructured":"Aldrighetti, L. et al. Liver resection with portal vein thrombectomy for hepatocellular carcinoma with vascular invasion. Ann. Surg. Oncol. 16, 1254 (2009).","journal-title":"Ann. Surg. Oncol."},{"key":"37807_CR4","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani, C. et al. Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391, 1023\u20131075 (2018).","journal-title":"Lancet"},{"key":"37807_CR5","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","volume":"169","author":"IA Roundtree","year":"2017","unstructured":"Roundtree, I. A., Evans, M. E., Pan, T. & He, C. Dynamic RNA modifications in gene expression regulation. Cell 169, 1187\u20131200 (2017).","journal-title":"Cell"},{"key":"37807_CR6","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature24482","volume":"551","author":"SK Natchiar","year":"2017","unstructured":"Natchiar, S. K., Myasnikov, A. G., Kratzat, H., Hazemann, I. & Klaholz, B. P. Visualization of chemical modifications in the human 80S ribosome structure. Nature 551, 472\u2013477 (2017).","journal-title":"Nature"},{"key":"37807_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108544","volume":"33","author":"B Rong","year":"2020","unstructured":"Rong, B. et al. Ribosome 18S m(6)A methyltransferase METTL5 promotes translation initiation and breast cancer cell growth. Cell Rep. 33, 108544 (2020).","journal-title":"Cell Rep."},{"key":"37807_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.617174","volume":"11","author":"S Sun","year":"2020","unstructured":"Sun, S. et al. Construction and comprehensive analyses of a METTL5-associated prognostic signature with immune implication in lung adenocarcinomas. Front. Genet. 11, 617174 (2020).","journal-title":"Front. Genet."},{"key":"37807_CR9","doi-asserted-by":"publisher","first-page":"6608","DOI":"10.3934\/mbe.2021327","volume":"18","author":"X Yan","year":"2021","unstructured":"Yan, X., Zhao, X., Yan, Q., Wang, Y. & Zhang, C. Analysis of the role of METTL5 as a hub gene in lung adenocarcinoma based on a weighted gene co-expression network. Math. Biosci. Eng. 18, 6608\u20136619 (2021).","journal-title":"Math. Biosci. Eng."},{"key":"37807_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/cancers11081085","volume":"11","author":"P Viveiros","year":"2019","unstructured":"Viveiros, P., Riaz, A., Lewandowski, R. J. & Mahalingam, D. Current state of liver-directed therapies and combinatory approaches with systemic therapy in hepatocellular carcinoma (HCC). Cancers (Basel) 11, 258 (2019).","journal-title":"Cancers (Basel)"},{"key":"37807_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12935-019-0901-3","volume":"19","author":"B Ding","year":"2019","unstructured":"Ding, B. et al. In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC. Cancer Cell Int. 19, 186 (2019).","journal-title":"Cancer Cell Int."},{"key":"37807_CR12","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3389\/fimmu.2019.02048","volume":"10","author":"Y Chen","year":"2019","unstructured":"Chen, Y. & Tian, Z. HBV-induced immune imbalance in the development of HCC. Front. Immunol. 10, 2048 (2019).","journal-title":"Front. Immunol."},{"key":"37807_CR13","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1245\/s10434-018-6730-0","volume":"25","author":"S Famularo","year":"2018","unstructured":"Famularo, S. et al. Recurrence patterns after anatomic or parenchyma-sparing liver resection for hepatocarcinoma in a western population of cirrhotic patients. Ann. Surg. Oncol. 25, 3974\u20133981 (2018).","journal-title":"Ann. Surg. Oncol."},{"key":"37807_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"37807_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc.2017.104","volume":"18","author":"J Pelletier","year":"2018","unstructured":"Pelletier, J., Thomas, G. & Volarevi\u0107, S. Ribosome biogenesis in cancer: New players and therapeutic avenues. Nat. Rev. Cancer 18, 51\u201363 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"37807_CR16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/0022-2836(86)90498-5","volume":"189","author":"BE Maden","year":"1986","unstructured":"Maden, B. E. Identification of the locations of the methyl groups in 18 S ribosomal RNA from Xenopus laevis and man. J. Mol. Biol. 189, 681\u2013699 (1986).","journal-title":"J. Mol. Biol."},{"key":"37807_CR17","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1093\/nar\/gkz619","volume":"47","author":"N van Tran","year":"2019","unstructured":"van Tran, N. et al. The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112. Nucleic Acids Res. 47, 7719\u20137733 (2019).","journal-title":"Nucleic Acids Res."},{"key":"37807_CR18","first-page":"1","volume":"2022","author":"W Xu","year":"2022","unstructured":"Xu, W., Liu, S., Zhang, G., Liu, J. & Cao, G. Knockdown of METTL5 inhibits the Myc pathway to downregulate PD-L1 expression and inhibits immune escape of hepatocellular carcinoma cells. J. Chemother. 2022, 1\u201310 (2022).","journal-title":"J. Chemother."},{"key":"37807_CR19","first-page":"1","volume":"60","author":"H Huang","year":"2022","unstructured":"Huang, H. et al. Ribosome 18S m(6)A methyltransferase METTL5 promotes pancreatic cancer progression by modulating c-Myc translation. Int. J. Oncol. 60, 1 (2022).","journal-title":"Int. J. Oncol."},{"key":"37807_CR20","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s42255-022-00622-9","volume":"4","author":"H Peng","year":"2022","unstructured":"Peng, H. et al. N(6)-methyladenosine (m(6)A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation. Nat. Metab. 4, 1041\u20131054 (2022).","journal-title":"Nat. Metab."},{"key":"37807_CR21","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1080\/21655979.2022.2036912","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu, X., Ma, H., Ma, L., Li, K. & Kang, Y. The potential role of methyltransferase-like 5 in deficient mismatch repair of uterine corpus endometrial carcinoma. Bioengineered 13, 5525\u20135536 (2022).","journal-title":"Bioengineered"},{"key":"37807_CR22","doi-asserted-by":"publisher","first-page":"6220","DOI":"10.1038\/s41598-018-24437-5","volume":"8","author":"N Rohr-Udilova","year":"2018","unstructured":"Rohr-Udilova, N. et al. Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma. Sci. Rep. 8, 6220 (2018).","journal-title":"Sci. Rep."},{"key":"37807_CR23","doi-asserted-by":"publisher","first-page":"e13301","DOI":"10.1097\/MD.0000000000013301","volume":"97","author":"W Ding","year":"2018","unstructured":"Ding, W. et al. Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma: A meta-analysis. Med. (Baltim.) 97, e13301 (2018).","journal-title":"Med. (Baltim.)"},{"key":"37807_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/ijms20030529","volume":"20","author":"R Mizuno","year":"2019","unstructured":"Mizuno, R. et al. The role of tumor-associated neutrophils in colorectal cancer. Int. J. Mol. Sci. 20, 529 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"37807_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12943-019-0976-4","volume":"18","author":"C Wei","year":"2019","unstructured":"Wei, C. et al. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Mol. Cancer 18, 64 (2019).","journal-title":"Mol. Cancer"},{"key":"37807_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/intimm\/8.5.765","volume":"8","author":"Y Agata","year":"1996","unstructured":"Agata, Y. et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8, 765\u2013772 (1996).","journal-title":"Int. Immunol."},{"key":"37807_CR27","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","volume":"26","author":"ME Keir","year":"2008","unstructured":"Keir, M. E., Butte, M. J., Freeman, G. J. & Sharpe, A. H. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26, 677\u2013704 (2008).","journal-title":"Annu. Rev. Immunol."},{"key":"37807_CR28","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1182\/blood-2007-05-085159","volume":"111","author":"R Yamamoto","year":"2008","unstructured":"Yamamoto, R. et al. PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma. Blood 111, 3220\u20133224 (2008).","journal-title":"Blood"},{"key":"37807_CR29","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1084\/jem.20082492","volume":"206","author":"KS Peggs","year":"2009","unstructured":"Peggs, K. S., Quezada, S. A., Chambers, C. A., Korman, A. J. & Allison, J. P. Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. J. Exp. Med. 206, 1717\u20131725 (2009).","journal-title":"J. Exp. Med."},{"key":"37807_CR30","doi-asserted-by":"publisher","first-page":"898964","DOI":"10.3389\/fonc.2022.898964","volume":"12","author":"T Ouyang","year":"2022","unstructured":"Ouyang, T., Kan, X. & Zheng, C. Immune checkpoint inhibitors for advanced hepatocellular carcinoma: Monotherapies and combined therapies. Front. Oncol. 12, 898964 (2022).","journal-title":"Front. Oncol."},{"key":"37807_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2021.108376","volume":"787","author":"R Marima","year":"2021","unstructured":"Marima, R., Hull, R., Penny, C. & Dlamini, Z. Mitotic syndicates Aurora Kinase B (AURKB) and mitotic arrest deficient 2 like 2 (MAD2L2) in cohorts of DNA damage response (DDR) and tumorigenesis. Mutat. Res. Rev. Mutat. Res. 787, 108376 (2021).","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"37807_CR32","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.2174\/1386207325666220301105850","volume":"25","author":"Y Lu","year":"2022","unstructured":"Lu, Y. et al. Overexpression of ribosomal protein S6 kinase A4 (RPS6KA4) predicts a poor prognosis in hepatocellular carcinoma patients: A study based on TCGA samples. Comb. Chem. High Throughput Screen 25, 2165\u20132179 (2022).","journal-title":"Comb. Chem. High Throughput Screen"},{"key":"37807_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/ncb1094","volume":"6","author":"DJ Webb","year":"2004","unstructured":"Webb, D. J. et al. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat. Cell Biol. 6, 154\u2013161 (2004).","journal-title":"Nat. Cell Biol."},{"key":"37807_CR34","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1242\/jcs.00993","volume":"117","author":"NG Dulyaninova","year":"2004","unstructured":"Dulyaninova, N. G., Patskovsky, Y. V. & Bresnick, A. R. The N-terminus of the long MLCK induces a disruption in normal spindle morphology and metaphase arrest. J. Cell Sci. 117, 1481\u20131493 (2004).","journal-title":"J. Cell Sci."},{"key":"37807_CR35","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.canlet.2008.05.028","volume":"270","author":"X Zhou","year":"2008","unstructured":"Zhou, X. et al. Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1\/2. Cancer Lett. 270, 312\u2013327 (2008).","journal-title":"Cancer Lett."},{"key":"37807_CR36","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.7314\/APJCP.2015.16.14.5835","volume":"16","author":"DB Zou","year":"2015","unstructured":"Zou, D. B. et al. Melatonin inhibits the migration of colon cancer RKO cells by down-regulating myosin light chain kinase expression through cross-talk with p38 MAPK. Asian Pac. J. Cancer Prev. 16, 5835\u20135842 (2015).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"37807_CR37","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","volume":"20","author":"J Hayes","year":"2014","unstructured":"Hayes, J., Peruzzi, P. P. & Lawler, S. MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol. Med. 20, 460\u2013469 (2014).","journal-title":"Trends Mol. Med."},{"key":"37807_CR38","doi-asserted-by":"publisher","first-page":"23581","DOI":"10.1002\/jcp.28927","volume":"234","author":"L Qin","year":"2019","unstructured":"Qin, L. et al. Integrated analysis of clinical significance and functional involvement of microRNAs in hepatocellular carcinoma. J. Cell Physiol. 234, 23581\u201323595 (2019).","journal-title":"J. Cell Physiol."},{"key":"37807_CR39","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.3748\/wjg.v24.i24.2596","volume":"24","author":"Y An","year":"2018","unstructured":"An, Y. et al. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma. World J. Gastroenterol. 24, 2596\u20132604 (2018).","journal-title":"World J. Gastroenterol."},{"key":"37807_CR40","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/cas.12869","volume":"107","author":"L Huan","year":"2016","unstructured":"Huan, L. et al. MicroRNA-127-5p targets the biliverdin reductase B\/nuclear factor-\u03baB pathway to suppress cell growth in hepatocellular carcinoma cells. Cancer Sci. 107, 258\u2013266 (2016).","journal-title":"Cancer Sci."},{"key":"37807_CR41","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/carcin\/bgr199","volume":"32","author":"J Lin","year":"2011","unstructured":"Lin, J. et al. MicroRNA-423 promotes cell growth and regulates G(1)\/S transition by targeting p21Cip1\/Waf1 in hepatocellular carcinoma. Carcinogenesis 32, 1641\u20131647 (2011).","journal-title":"Carcinogenesis"},{"key":"37807_CR42","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.3892\/mmr.2015.3704","volume":"12","author":"D Chen","year":"2015","unstructured":"Chen, D. et al. Downregulated microRNA-510-5p acts as a tumor suppressor in renal cell carcinoma. Mol. Med. Rep. 12, 3061\u20133066 (2015).","journal-title":"Mol. Med. Rep."},{"key":"37807_CR43","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45, W98\u2013W102 (2017).","journal-title":"Nucleic Acids Res."},{"key":"37807_CR44","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar, D. S. et al. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19, 649\u2013658 (2017).","journal-title":"Neoplasia"},{"key":"37807_CR45","doi-asserted-by":"publisher","first-page":"e27633","DOI":"10.2196\/27633","volume":"23","author":"A L\u00e1nczky","year":"2021","unstructured":"L\u00e1nczky, A. & Gy\u0151rffy, B. Web-based survival analysis tool tailored for medical research (KMplot): Development and implementation. J. Med. Internet Res. 23, e27633 (2021).","journal-title":"J. Med. Internet Res."},{"key":"37807_CR46","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/pmic.201100504","volume":"12","author":"A Asplund","year":"2012","unstructured":"Asplund, A., Edqvist, P. H., Schwenk, J. M. & Pont\u00e9n, F. Antibodies for profiling the human proteome\u2014The Human Protein Atlas as a resource for cancer research. Proteomics 12, 2067\u20132077 (2012).","journal-title":"Proteomics"},{"key":"37807_CR47","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal 6, pl1 (2013).","journal-title":"Sci. Signal"},{"key":"37807_CR48","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar, S. V., Straub, P., Wang, J. & Zhang, B. LinkedOmics: Analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 46, D956\u2013D963 (2018).","journal-title":"Nucleic Acids Res."},{"key":"37807_CR49","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"37807_CR50","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley, D. et al. The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 38, W214-220 (2010).","journal-title":"Nucleic Acids Res."},{"key":"37807_CR51","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li, T. et al. TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 77, e108\u2013e110 (2017).","journal-title":"Cancer Res."},{"key":"37807_CR52","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru, B. et al. TISIDB: An integrated repository portal for tumor-immune system interactions. Bioinformatics 35, 4200\u20134202 (2019).","journal-title":"Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37807-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37807-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37807-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T18:11:38Z","timestamp":1688407898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37807-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["37807"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-37807-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"assertion":[{"value":"10 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10755"}}